ArticleCancers2023

Plasma Markers for Therapy Response Monitoring in Patients with Neuroendocrine Tumors Undergoing Peptide Receptor Radionuclide Therapy.

Christoph Wetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.